Prudential Financial Inc. lowered its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 32.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 112,452 shares of the company's stock after selling 54,400 shares during the period. Prudential Financial Inc. owned approximately 0.23% of Nu Skin Enterprises worth $775,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the stock. BNP Paribas Financial Markets lifted its holdings in Nu Skin Enterprises by 69.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 143,319 shares of the company's stock worth $1,056,000 after purchasing an additional 58,880 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Nu Skin Enterprises by 3.7% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 116,424 shares of the company's stock worth $858,000 after buying an additional 4,125 shares during the last quarter. Verition Fund Management LLC bought a new stake in shares of Nu Skin Enterprises during the 3rd quarter worth $581,000. Centiva Capital LP acquired a new position in Nu Skin Enterprises in the 3rd quarter valued at $508,000. Finally, Jane Street Group LLC raised its holdings in Nu Skin Enterprises by 358.4% in the 3rd quarter. Jane Street Group LLC now owns 924,993 shares of the company's stock worth $6,817,000 after acquiring an additional 723,220 shares during the period. Institutional investors and hedge funds own 82.84% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently issued reports on NUS. DA Davidson lowered their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating on the stock in a research report on Friday, December 20th. StockNews.com downgraded Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Tuesday.
Read Our Latest Stock Analysis on Nu Skin Enterprises
Nu Skin Enterprises Stock Performance
Nu Skin Enterprises stock traded up $0.16 during mid-day trading on Friday, reaching $6.23. The company had a trading volume of 1,151,522 shares, compared to its average volume of 831,479. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. The firm has a market cap of $309.53 million, a price-to-earnings ratio of -2.11 and a beta of 1.10. The company has a 50 day moving average of $7.28 and a 200-day moving average of $7.03. Nu Skin Enterprises, Inc. has a 52 week low of $5.75 and a 52 week high of $14.00.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. The business had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. On average, sell-side analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were issued a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 3.86%. The ex-dividend date was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -8.14%.
About Nu Skin Enterprises
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Stories

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.